Movement Alert|Medpace Holdings Rises 7.2% in Regular Trading, Trading at $507.6

Market Focus
06/25

On June 24, Medpace Holdings rose 7.2% in regular trading, trading at $507.6 USD/share, with Turnover of $90.19 million.

Within the Life Sciences Tools & Services sector where Medpace Holdings belongs, the overall sector showed broad strength. Among individual stocks, Icon PLC up 12.34%, Illumina up 6.33%, Danaher up 4.9%, Mettler-Toledo up 4.38%, Thermo Fisher Scientific up 3.98%.

Medpace Holdings is a global leading clinical contract research organization (CRO), specializing in science-driven outsourced clinical development services for the biotechnology, pharmaceutical, and medical device industries, covering Phase I through Phase IV clinical development with particular strength in oncology, metabolic diseases, and cardiology.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10